Chemoprophylaxis
Showing 1 - 25 of 193
Malaria, Chemoprophylaxis, Underfive Children Trial in Dar es Salaam (Dihydroartemisinin-piperaquine)
Completed
- Malaria
- +2 more
-
Dar es Salaam, TanzaniaMuhimbili University of Health and Allied Ssciences
May 15, 2023
Malaria, Malaria,Falciparum Trial in Ouagadougou (Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH
Not yet recruiting
- Malaria
- Malaria,Falciparum
- Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH without DOT
- +2 more
-
Ouagadougou, Burkina FasoGroupe de Recherche Action en Santé
May 18, 2023
Pulmonary Embolism, Thoracic Surgery Trial in Shanghai (Chemoprophylaxis with Low Molecular Weight Heparin (LMWH))
Completed
- Pulmonary Embolism
- Thoracic Surgery
- Chemoprophylaxis with Low Molecular Weight Heparin (LMWH)
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 5, 2021
Deep Venous Thrombosis, Colonic Cancer Trial in São Paulo (Rivaroxaban 10 MG)
Not yet recruiting
- Deep Venous Thrombosis
- Colonic Cancer
- Rivaroxaban 10 MG
-
São Paulo, SP, BrazilHospital do Servidor Público Estadual de São Paulo
Mar 21, 2022
Tuberculosis Infection, Tuberculosis Trial (BCG vaccine, Oral Chemoprophylaxis)
Not yet recruiting
- Tuberculosis Infection
- Tuberculosis
- BCG vaccine
- Oral Chemoprophylaxis
- (no location specified)
Jul 4, 2022
Malaria Trial in Bamako (Chloroquine Phosphate, PfSPZ Challenge, Pyrimethamine)
Completed
- Malaria
- Chloroquine Phosphate
- +4 more
-
Bamako, MaliMalaria Vaccine Center STTB/MRTC
Jun 21, 2022
COVID-19, Severe Acute Respiratory Syndrome Trial in Mexico, City (Hydroxychloroquine, Placebo oral tablet)
Completed
- COVID-19
- Severe Acute Respiratory Syndrome
- Hydroxychloroquine
- Placebo oral tablet
-
Mexico, City, MexicoInstituto Nacional de Enfermedades Respiratorias, "Ismael Cosío
Jan 17, 2022
COVID 19, Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors Trial
Withdrawn
- COVID 19
- Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors
- Hidroxicloroquina
- Control group
- (no location specified)
Sep 8, 2021
Malaria Trial (Pyronaridine Tetraphosphate, Artesunate Drug Combination, PfSPZ Challenge (NF54), MVA ME-TRAP)
Not yet recruiting
- Malaria
- Pyronaridine Tetraphosphate, Artesunate Drug Combination
- +4 more
- (no location specified)
Jun 27, 2022
Bacterial Sexually Transmitted Diseases Trial (Doxycycline Hyclate)
Not yet recruiting
- Bacterial Sexually Transmitted Diseases
- Doxycycline Hyclate
- (no location specified)
Feb 16, 2021
Influenza, Exposure, Prevention Trial in Warsaw (Oseltamivir 3 days, Oseltamivir 7 days)
Unknown status
- Influenza
- +2 more
- Oseltamivir 3 days
- Oseltamivir 7 days
-
Warsaw, Mazowieckie, PolandThe Centre of Postgraduate Medical Education
Sep 7, 2020
Malaria Trial run by the NIAID (Chloroquine Phosphate, Pyrimethamine, Sanaria PfSPZ Challenge)
Completed
- Malaria
- Chloroquine Phosphate
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 5, 2021
Plasmodium Falciparum, Malaria Trial in Tübingen (DSM265 400mg, Placebo to DSM265 400 mg, Plasmodium falciparum sporozoite
Completed
- Plasmodium Falciparum, Malaria
- DSM265 400mg
- +3 more
-
Tübingen, GermanyUniversitätsklinikum Tübingen, Institut für Tropenmedizin
Jan 7, 2021
COVID-19 Trial in Barcelona (Treatment and prophylaxis, Standard Public Health measures)
Completed
- COVID-19
- Treatment and prophylaxis
- Standard Public Health measures
-
Barcelona, SpainDepartament de Salut
Jun 26, 2020
HIV Trial in Worldwide (daily TDF/FTC, Placebo)
Completed
- HIV Infections
- daily TDF/FTC
- Placebo
-
San Francisco, California
- +10 more
Oct 29, 2021
Sars-CoV2, Coronavirus Infection, Prevention & Control Trial (Hydroxychloroquine Only Product in Oral Dose Form)
Not yet recruiting
- Sars-CoV2
- +4 more
- Hydroxychloroquine Only Product in Oral Dose Form
- (no location specified)
Sep 26, 2020
COVID-19 Trial in Cambridge (Hydroxychloroquine - Daily dosing, Hydroxychloroquine - Weekly Dosing, Matched Placebo
Unknown status
- COVID-19
- Hydroxychloroquine - Daily dosing
- +2 more
-
Cambridge, United KingdomCambridge University Hospitals NHS Foundation Trust
May 11, 2020
Crohn Disease, Ulcerative Colitis, Venous Thromboembolism Trial in Cleveland (Aspirin 81Mg Ec Tab, Standard of Care)
Not yet recruiting
- Crohn Disease
- +2 more
- Aspirin 81Mg Ec Tab
- Standard of Care
-
Cleveland, OhioCleveland Clinic Main Campus
Jul 19, 2022
Venous Thromboembolism Trial in Stanford (Apixaban 2.5 MG Oral Tablet, Enoxaparin 40Mg/0.4mL Prefilled Syringe)
Recruiting
- Venous Thromboembolism
- Apixaban 2.5 MG Oral Tablet
- Enoxaparin 40Mg/0.4mL Prefilled Syringe
-
Stanford, CaliforniaStanford University Medical Center
Mar 16, 2022
Travelers' Diarrhea, Functional Bowel Disorders, Reactive Arthritis Trial in Kenya, United States (Rifaximin, Placebo)
Unknown status
- Travelers' Diarrhea
- +2 more
- Rifaximin
- Placebo
-
San Diego, California
- +5 more
Nov 25, 2019
COVID-19, SARS-CoV-2 Trial in Toronto (Favipiravir, Favipiravir Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- Favipiravir
- Favipiravir Placebo
-
Toronto, Ontario, CanadaMount Sinai Hospital
Aug 11, 2021
Malaria Trial (drug, biological, other)
Completed
- Malaria
- atovaquone/proguanil 250mg/100mg (A/P)
- +2 more
- (no location specified)
Jul 11, 2019